Condition (MeSH)
Serum Sickness
ClinicalTrials.gov lists 1 trial for Serum Sickness or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section
5 sections measured, none recorded · 1 not measured yet · 1 not computed
1 of the 1 trial is tagged with Serum Sickness itself; the rest are tagged with a narrower condition beneath it.
When did Serum Sickness trials start? (1)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2010 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 1 trial evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Serum Sickness trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Observational | 1 |
How many Serum Sickness trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Serum Sickness? (8)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Presumptive serum sickness as a complication of rabbit-derived antithymocyte globulin immunosuppression. | Arthritis and rheumatism | 2009 | Yes |
| Human serum sickness. | Clinical reviews in allergy | 1985 | Yes |
| Hypersensitivity reactions associated with botulinal antitoxin. | The American journal of medicine | 1980 | Yes |
| Safety and tolerability of omalizumab (Xolair), a recombinant humanized monoclonal anti-IgE antibody. | Clinical reviews in allergy & immunology | 2005 | No |
| Incidence of immediate and delayed hypersensitivity to Centruroides antivenom. | Annals of emergency medicine | 1999 | No |
Showing 5 of 8 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.